Health Care · covered US companies
Biotechnology stocks, compared by the numbers
Explore valuation, revenue growth, operating margins and research scores side by side. Each metric is ranked separately—this is context, not a “best stock” list.
3 of 3 covered companies loaded.
| Company | Price | P/E ↓ | Revenue growth ↑ | Operating margin ↑ | Research score ↑ |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $231.35 | — | #2 13.1% | #3 -116.0% | #3 47/100 |
| Regeneron Pharmaceuticals, Inc. (REGN) | $951.19 | #1 21.0x | #1 18.6% | #2 28.8% | #1 78/100 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $542.62 | #2 34.9x | #3 10.5% | #1 33.2% | #2 71/100 |
Ranks compare only covered companies in this catalogue industry. Lower positive P/E ranks better; higher revenue growth, operating margin and research score rank better. Ties share a rank and missing values are excluded.